Superior vena cava syndrome associated with implantable cardiac devices procedures
Journal Title: Journal of Rare Cardiovascular Diseases - Year 2019, Vol 4, Issue 1
Abstract
INTRODUCTION: Superior vena cava (SVC) syndrome is a rare clinical disorder associated with obstructing venous outflow through the SVC. Although the most common cause is mediastinal tumors, the growing number of implantable cardiac devices procedures has resulted in more patients with SVC syndrome of non‐malignant etiology. DISCUSSION: It has been shown repeatedly that the use of cardiac implantable electronic devices (CIEDs) improves the quality of life of patients with symptomatic arrhythmias and reduces the mortality of patients at risk of sudden cardiac death, but the risk of complications also exists. CONCLUSION: The most common finding in patients with cardiac devices is asymptomatic venous thrombosis, but serious complications, including SVC obstruction should always be considered. The rapid identification of clinical symptoms and the implementation of appropriate measures are a key to preventing the morbidity and mortality of the patients. JRCD 2018; 4 (1): 5–8
Authors and Affiliations
Szymon Jonik, Łukasz Januszkiewicz
Keywords
Related Articles
- EP ID EP561563
- DOI 10.2041/jrcd.vol4no1.349
- Views 97
- Downloads 0
Influence of disease‑related heart pathology on peak oxygen uptake and ventilation/carbon dioxide output ratio in systemic sclerosis and systemic lupus erythematosus patients (RCD code: I-3C)
Background: Exercise capacity is an independent predictor of mortality in the general population. However, available literature has been focused mainly on exercise testing in patients with ischaemic heart failure. Little...
Biventricular cardiomyopathy improvement by shifting therapy from agalsidase alfa to agalsidase beta in Anderson‐Fabry Disease
Treatment of Fabry disease has improved since the introduction of enzyme replacement therapy (ERT). Two preparations of the recom‐ binant enzyme α‐galactosidase A are available: agalsidase alfa and agalsidase beta. We ai...
Successful reversal of advanced heart failure due to peripartum cardiomyopathy with aggressive pharmacotherapy and a continuous‑flow left ventricular assist device (RCD code: III-1B.8c)
Peripartum cardiomyopathy (PPCM) is a rare but potentially devastating complication of pregnancy. PPCM is not well understood and relatively little is known about its epidemiology and pathogenesis. However, it appears to...
Venous system anomaly as a reason for misplacement of pacemaker lead (RCD code: IV1C.1)
We present a case of a 45-year old patient with history of surgical ASD II closure and pacemaker implantation who was only recently diagnosed with lead mispalcement due to anomalous venous return.
Effusive‐constrictive pericarditis in a patient with end‐stage renal disease
Renal disease, especially end‐stage renal disease, is associated with possible pericardial involvement. We report the case of a 51‐year‐old patient with a history of end‐stage‐renal disease, currently receiving chronic h...